We believe this decreased production of type I IFNs is a major contributor to the prevalence and severity of COVID-19 because it would increase the levels of circulating CHI3L1, increase the expression and accumulation of ACE2 and SPP, and augment viral infection and spread. This evidence concerns the gene ACE2 and viral infectious disease.